NO20002283L - FremgangsmÕte ved fremstilling av spraygranuler inneholdende riboflavin - Google Patents

FremgangsmÕte ved fremstilling av spraygranuler inneholdende riboflavin

Info

Publication number
NO20002283L
NO20002283L NO20002283A NO20002283A NO20002283L NO 20002283 L NO20002283 L NO 20002283L NO 20002283 A NO20002283 A NO 20002283A NO 20002283 A NO20002283 A NO 20002283A NO 20002283 L NO20002283 L NO 20002283L
Authority
NO
Norway
Prior art keywords
preparation
spray drying
drying process
granules containing
spray granules
Prior art date
Application number
NO20002283A
Other languages
English (en)
Other versions
NO20002283D0 (no
NO318219B1 (no
Inventor
Markus Nowotny
Jean-Claude Tritsch
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8238078&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20002283(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of NO20002283D0 publication Critical patent/NO20002283D0/no
Publication of NO20002283L publication Critical patent/NO20002283L/no
Publication of NO318219B1 publication Critical patent/NO318219B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J3/00—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms
    • A61J3/06—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms into the form of pills, lozenges or dragees
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1688—Processes resulting in pure drug agglomerate optionally containing up to 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/525—Isoalloxazines, e.g. riboflavins, vitamin B2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D475/00—Heterocyclic compounds containing pteridine ring systems
    • C07D475/12—Heterocyclic compounds containing pteridine ring systems containing pteridine ring systems condensed with carbocyclic rings or ring systems
    • C07D475/14—Benz [g] pteridines, e.g. riboflavin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Nutrition Science (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NO20002283A 1999-04-30 2000-04-28 Fremgangsmate ved fremstilling av spraygranuler inneholdende riboflavin NO318219B1 (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP99108476 1999-04-30

Publications (3)

Publication Number Publication Date
NO20002283D0 NO20002283D0 (no) 2000-04-28
NO20002283L true NO20002283L (no) 2000-10-31
NO318219B1 NO318219B1 (no) 2005-02-21

Family

ID=8238078

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20002283A NO318219B1 (no) 1999-04-30 2000-04-28 Fremgangsmate ved fremstilling av spraygranuler inneholdende riboflavin

Country Status (16)

Country Link
US (1) US6723346B1 (no)
EP (1) EP1048668B2 (no)
JP (1) JP4965013B2 (no)
KR (1) KR100720202B1 (no)
CN (1) CN1198595C (no)
AT (1) ATE231864T1 (no)
AU (1) AU770320B2 (no)
BR (1) BR0002390A (no)
CA (1) CA2306502A1 (no)
DE (1) DE60001286T3 (no)
DK (1) DK1048668T3 (no)
ES (1) ES2189711T5 (no)
ID (1) ID25698A (no)
MX (1) MXPA00004185A (no)
NO (1) NO318219B1 (no)
TW (1) TWI253347B (no)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0219815D0 (en) * 2002-08-24 2002-10-02 Accentus Plc Preparation of small crystals
DE10317051A1 (de) 2003-04-11 2004-10-21 Basf Ag Verfahren zur Herstellung von Riboflavin der Modifikation B/C in Granulatform
ATE442369T1 (de) 2003-07-22 2009-09-15 Dsm Ip Assets Bv Verfahren zur aufreinigung von riboflavin
US8689459B2 (en) * 2006-12-07 2014-04-08 Friesland Brands B.V. Method and apparatus for spray drying and powder produced using said method
CN104961740B (zh) * 2015-06-02 2016-04-27 湖北广济药业股份有限公司 一种含核黄素的固体制剂及其制备方法
ES2949057T3 (es) 2018-11-07 2023-09-25 Dsm Ip Assets Bv Medicamentos con contenido en riboflavina que exhiben una fluidez mejorada

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0307767B1 (en) * 1987-09-18 1993-07-21 F. Hoffmann-La Roche Ag Novel form of riboflavin
DE3819745A1 (de) * 1988-06-10 1989-12-14 Basf Ag Verfahren zur herstellung von auf mikrobiellem wege hergestelltem riboflavin in form von sprueh- oder mikrogranulaten
JP2634285B2 (ja) * 1989-03-28 1997-07-23 積水化学工業株式会社 放射性物質取扱所の被覆材用非灰分性樹脂組成物
DE3927810A1 (de) 1989-08-23 1991-02-28 Basf Ag Riboflavingranulate
US4994458A (en) * 1990-04-30 1991-02-19 Basf Corporation Process for rotary fluid bed granulation of riboflavin
US5236920A (en) * 1990-04-30 1993-08-17 Basf Corporation Granulated riboflavin product having high flowability, high riboflavin content
DE4014262A1 (de) 1990-05-04 1991-11-07 Basf Ag Gut rieselfaehige, nichtstaubende bindemittelfreie riboflavinspruehgranulate oder -mikrogranulate aus reinem riboflavin und ein verfahren zu deren herstellung
US5000888A (en) * 1990-05-23 1991-03-19 Basf Corporation Process for spray drying riboflavin to produce a granulate product having low binder content
JP2000112883A (ja) * 1998-09-24 2000-04-21 Internatl Business Mach Corp <Ibm> 情報処理方法、情報処理装置、情報処理プログラムを格納する記憶媒体
CA2282908A1 (en) 1998-10-19 2000-04-19 F. Hoffmann-La Roche Ag Purification and crystallization process for riboflavin
US6093715A (en) * 1999-03-24 2000-07-25 Basf Aktiengesellschaft Process for producing riboflavin-containing granules

Also Published As

Publication number Publication date
ES2189711T3 (es) 2003-07-16
KR100720202B1 (ko) 2007-05-21
EP1048668A3 (en) 2001-03-28
CN1275375A (zh) 2000-12-06
EP1048668B1 (en) 2003-01-29
KR20010029668A (ko) 2001-04-06
JP2000327562A (ja) 2000-11-28
CA2306502A1 (en) 2000-10-30
DE60001286T3 (de) 2010-10-28
AU770320B2 (en) 2004-02-19
ID25698A (id) 2000-11-02
EP1048668A2 (en) 2000-11-02
DE60001286T2 (de) 2003-11-06
JP4965013B2 (ja) 2012-07-04
ES2189711T5 (es) 2010-07-28
EP1048668B2 (en) 2010-06-09
NO20002283D0 (no) 2000-04-28
DK1048668T3 (da) 2003-05-26
NO318219B1 (no) 2005-02-21
US6723346B1 (en) 2004-04-20
AU3018900A (en) 2000-11-02
CN1198595C (zh) 2005-04-27
ATE231864T1 (de) 2003-02-15
TWI253347B (en) 2006-04-21
MXPA00004185A (es) 2002-03-08
BR0002390A (pt) 2000-10-31
DE60001286D1 (de) 2003-03-06

Similar Documents

Publication Publication Date Title
WO2000061568A3 (de) Mit zuckerresten substituierte 1,4-benzothiazepin-1,1-dioxidderivate, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung
CA2334775A1 (en) Benzo(b)thiepine-1,1-dioxide derivatives, a process for their preparation, pharmaceuticals comprising these compounds, and their use
MX9200817A (es) Derivados de piranil cianoguanidina y proceso para su preparacion.
AU2399388A (en) Method of crystallizing a zeolite on the surface of a monolithic ceramic substrate
AU5792690A (en) Aqeous pharmaceutical suspension for substantially water insoluble pharmaceutical actives
HUT62893A (en) Process for producing substituted pyrimidine derivatives and pharmaceutical compositions comprising such compounds as active ingredient
HUT64310A (en) Compositions containing substituted aryl-halogenalkyl-pyrazol derivatives having herbicidal activity and process for producing said compounds
FI102069B (fi) Menetelmä terapeuttisesti käyttökelpoisten indolijohdannaisten valmist amiseksi
CA2141874A1 (en) Process for the production of urea granules
BRPI0108374B8 (pt) derivado de pirazina ou um sal deste e composição farmacêutica
NO20002283D0 (no) FremgangsmÕte ved fremstilling av spraygranuler inneholdende riboflavin
ATE64548T1 (de) Granuliertes produkt.
FI931332A7 (fi) Uusia alkyleenidiammoniumdiklavulanaattijohdannaisia, menetelmä niidenvalmistamiseksi samoin kuin niiden käyttö kalvulaanihapon puhdistamiseksi
EP0994108A4 (en) METHOD FOR PRODUCING 2-HYDROXYBENZAMIDE DERIVATIVES
ES2147749T3 (es) Procedimiento para la preparacion de derivados de ciano-metoxiiminometilo.
HK1046902A1 (zh) 新型哌嗪基烷基硫代嘧啶衍生物，包含該衍生物的藥物組合物以及製備該活性物質的方法
CN101421254B (zh) 用双环基团n-取代的二氨基-1，3，5-三嗪、其制备方法、其组合物及其用作除草剂和植物生长调节剂的用途
DK0717042T3 (da) Fremgangsmåde til fremstilling af 1-(4,5-dihydro-2-thiazolyl)-3-azetidin-thiol-derivater
DE69833951D1 (de) Verfahren zur herstellung von substituierten alkylaminen oder salzen davon
DK0855398T3 (da) Sesquiterpenderivater med antiviral aktivitet
WO2001007439A3 (en) Process for the production of epothiolone b and derivatives as well as intermediate products for this process
FR2688503B1 (fr) Procede de preparation de derives de 2-(tetrazol-5-yl)-[1,1&#39;-biphenyle].
NO932231D0 (no) Fremgangsmaate for fremstilling av pyrrolinylacetamid-derivater
HRP20030543B1 (en) Stable granulates containing s-adenosylmethionine and process for the preparation thereof
DK0508233T3 (da) Fremgangsmåde til fremstilling af ascorbinsyre-2-monophosphater ved tørring